Methods for the Treatment or Prevention of Ischemic Tissue Damage Read more about Methods for the Treatment or Prevention of Ischemic Tissue Damage Patent Cooperation TreatyPCT/US2016/032194Filed on 2016-05-12
Human Monoclonal Antibodies Specific for Glypican-3 and Use Thereof Read more about Human Monoclonal Antibodies Specific for Glypican-3 and Use Thereof US Patent 9,932,406Filed on 2016-04-05
Synthetic Immunosuppressive Oligodeoxynucleotides Reduce Ischemic Tissue Damage Read more about Synthetic Immunosuppressive Oligodeoxynucleotides Reduce Ischemic Tissue Damage Patent Cooperation TreatyPCT/US2016/032192Filed on 2016-05-12
COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT Read more about COMPOUNDS THAT BIND TO HUMAN IMMUNODEFICIENCY VIRUS REV RESPONSE ELEMENT US Patent 10,464,970Filed on 2016-04-21
Hypoxia Inducible Factor 1 (HIF-1) Inhibitors Read more about Hypoxia Inducible Factor 1 (HIF-1) Inhibitors Patent Cooperation TreatyPCT/US2016/026145Filed on 2016-04-06
Ratio Based Biomarkers And Methods of Use Thereof Read more about Ratio Based Biomarkers And Methods of Use Thereof Australia2016202107Filed on 2016-04-05
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof Read more about Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof Hong Kong16108042.3Filed on 2012-04-19
Anti-SSX-2 T Cell Receptors and Related Materials and Methods of Use Read more about Anti-SSX-2 T Cell Receptors and Related Materials and Methods of Use US Patent 10,143,724Filed on 2016-04-19
METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD Read more about METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD Patent Cooperation TreatyPCT/US2016/030137Filed on 2016-04-29
Modified Pseudomonas Exotoxin A Read more about Modified Pseudomonas Exotoxin A Japan2016-520651Filed on 2016-04-06